Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Breast Cancer |
Free Subscription
2 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
High Peritumoral and Intratumoral T2 Signal Intensity in HER2+ Breast Cancers on
Preneoadjuvant Breast MRI: Assessment of Associations With Histopathologic
Characteristics.
AJR Am J Roentgenol. 2023 Dec 20. doi: 10.2214/AJR.23.30280.
PubMed
Abstract available
Evolving Treatment Paradigms for Low-Risk Ductal Carcinoma In Situ: Imaging
Needs.
AJR Am J Roentgenol. 2023 Dec 13. doi: 10.2214/AJR.23.30503.
PubMed
Abstract available
Cohort Studies Versus Case-Control Studies on Night-Shift Work and Cancer Risk:
The Importance of Exposure Assessment.
Am J Epidemiol. 2024;193:577-579.
PubMed
Abstract available
Remote Symptom Monitoring with Clinical Alerts Following Mastectomy: Do Early
Symptoms Predict 30-Day Surgical Complications.
Ann Surg Oncol. 2024;31:3377-3386.
PubMed
Abstract available
Determination of Factors Associated with Upstage in Atypical Ductal Hyperplasia
to Identify Low-Risk Patients Where Active Surveillance May be an Alternative.
Ann Surg Oncol. 2024;31:3177-3185.
PubMed
Abstract available
Understanding Breast Cancer Surgery Through Tiktok: an Analysis of Video Content
and Viewer Engagement.
Ann Surg Oncol. 2024 Apr 9. doi: 10.1245/s10434-024-15268.
PubMed
Abstract available
Long-term survival after neoadjuvant therapy for triple-negative breast cancer
under different treatment regimens: a systematic review and network
meta-analysis.
BMC Cancer. 2024;24:440.
PubMed
Abstract available
Pathway-based signatures predict patient outcome, chemotherapy benefit and
synthetic lethal dependencies in invasive lobular breast cancer.
Br J Cancer. 2024 Apr 10. doi: 10.1038/s41416-024-02679.
PubMed
Abstract available
Neratinib could be effective as monotherapy or in combination with trastuzumab in
HER2-low breast cancer cells and organoid models.
Br J Cancer. 2024 Apr 10. doi: 10.1038/s41416-024-02665.
PubMed
Abstract available
Acute adverse events of ultra-hypofractionated whole-breast irradiation after
breast-conserving surgery for early breast cancer in Japan: an interim analysis
of the multi-institutional phase II UPBEAT study.
Breast Cancer. 2024 Apr 12. doi: 10.1007/s12282-024-01577.
PubMed
Abstract available
Sacituzumab govitecan in metastatic triple-negative breast cancer patients
treated at Institut Curie Hospitals: efficacy, safety, and impact of brain
metastases.
Breast Cancer. 2024 Apr 10. doi: 10.1007/s12282-024-01565.
PubMed
Abstract available
Association between quality of life and mortality risk in patients with breast
cancer: a systematic review and meta-analysis.
Breast Cancer. 2024 Apr 9. doi: 10.1007/s12282-024-01581.
PubMed
Abstract available
Investigation of recurrence prediction ability of EndoPredict((R)) using microarray
data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and
indication expansion of EndoPredict((R)) from microarray data from fresh-frozen to
FFPE
Breast Cancer. 2024 Apr 8. doi: 10.1007/s12282-024-01573.
PubMed
Abstract available
Breast Cancer (Dove Med Press)
Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast
Cancer Patients.
Breast Cancer (Dove Med Press). 2024;16:163-179.
PubMed
Abstract available
Serum protein profiling reveals an inflammation signature as a predictor of early
breast cancer survival.
Breast Cancer Res. 2024;26:61.
PubMed
Abstract available
U2AF2-SNORA68 promotes triple-negative breast cancer stemness through the
translocation of RPL23 from nucleoplasm to nucleolus and c-Myc expression.
Breast Cancer Res. 2024;26:60.
PubMed
Abstract available
Clinical factors associated with patterns of endocrine therapy adherence in
premenopausal breast cancer patients.
Breast Cancer Res. 2024;26:59.
PubMed
Abstract available
Circulating tumour DNA dynamics during alternating chemotherapy and hormonal
therapy in metastatic breast cancer: the ALERT study.
Breast Cancer Res Treat. 2024 Apr 6. doi: 10.1007/s10549-024-07316.
PubMed
Abstract available
STK3 higher expression association with clinical characteristics in intrinsic
subtypes of breast cancer invasive ductal carcinoma patients.
Breast Cancer Res Treat. 2024 Apr 9. doi: 10.1007/s10549-024-07248.
PubMed
Abstract available
Clinical evaluation of deep learning-based risk profiling in breast cancer
histopathology and comparison to an established multigene assay.
Breast Cancer Res Treat. 2024 Apr 9. doi: 10.1007/s10549-024-07303.
PubMed
Abstract available
Recreational physical activity and breast cancer risk by menopausal status and
tumor hormone receptor status: results from the Nurses' Health Studies.
Breast Cancer Res Treat. 2024 Apr 9. doi: 10.1007/s10549-023-07238.
PubMed
Abstract available
Correction: Surgery of the primary tumor in patients with de novo metastatic
breast cancer: a nationwide population-based retrospective cohort study in
Belgium.
Breast Cancer Res Treat. 2024 Apr 9. doi: 10.1007/s10549-024-07275.
PubMed
Genetic interactions reveal distinct biological and therapeutic implications in
breast cancer.
Cancer Cell. 2024;42:701-719.
PubMed
Abstract available
XBP1s activates METTL3/METTL14 for ER-phagy and paclitaxel sensitivity regulation
in breast cancer.
Cancer Lett. 2024 Apr 4:216846. doi: 10.1016/j.canlet.2024.216846.
PubMed
Abstract available
SOD1-high fibroblasts derived exosomal miR-3960 promotes cisplatin resistance in
triple-negative breast cancer by suppressing BRSK2-mediated phosphorylation of
PIMREG.
Cancer Lett. 2024;590:216842.
PubMed
Abstract available
MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative Breast
Cancer.
Cancer Res. 2024 Apr 9:OF1-OF15. doi: 10.1158/0008-5472.CAN-23-3046.
PubMed
Abstract available
The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC).
Clin Breast Cancer. 2024 Mar 6:S1526-8209(24)00061.
PubMed
Abstract available
Is Immediate Breast Reconstruction With a Latissimus Dorsi Myocutaneous Flap Safe
for Starting Adjuvant Chemotherapy in Patients With Breast Cancer?
Clin Breast Cancer. 2024 Mar 10:S1526-8209(24)00076.
PubMed
Abstract available
Lung-derived soluble factors support stemness/plasticity and metastatic behaviour
of breast cancer cells via the FGF2-DACH1 axis.
Clin Exp Metastasis. 2024 Apr 6. doi: 10.1007/s10585-024-10284.
PubMed
Abstract available
Ovarian Suppression: Early Menopause and Late Effects.
Curr Treat Options Oncol. 2024;25:523-542.
PubMed
Abstract available
Single-cell transcriptomics reveals the intra-tumoral heterogeneity and
SQSTM1/P62 and Wnt/beta-catenin mediated epithelial to mesenchymal transition and
stemness of triple-negative breast cancer.
Exp Cell Res. 2024 Apr 5:114032. doi: 10.1016/j.yexcr.2024.114032.
PubMed
Abstract available
Breast cancer drug resistance: Decoding the roles of Hippo pathway crosstalk.
Gene. 2024;916:148424.
PubMed
Abstract available
Investigating the effect of hesperetin on estrogen receptor alpha (ERalpha)
expression, phosphorylation and activity in MCF-7 cells.
Gene. 2024;911:148357.
PubMed
Abstract available
Newly Diagnosed Mental Health Disorders in Patients with Breast Cancer Receiving
Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2024 Apr 4:S0360-3016(24)00445.
PubMed
Abstract available
Surviving without BRCA2: MLH1 gets R-looped in to curtail genomic instability.
J Clin Invest. 2024;134:e179325.
PubMed
Abstract available
Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human
Epidermal Growth Factor 2-Negative Breast Cancer.
J Clin Oncol. 2024 Apr 9:JCO2302614. doi: 10.1200/JCO.23.02614.
PubMed
RE: Supplemental magnetic resonance imaging plus mammography compared with
magnetic resonance imaging or mammography by extent of breast density.
J Natl Cancer Inst. 2024;116:627-628.
PubMed
Familial uveal melanoma and other tumors in 25 families with monoallelic germline
MBD4 variants.
J Natl Cancer Inst. 2024;116:580-587.
PubMed
Abstract available
Breast Cancer and Pregnancy in Young BRCA Carriers.
JAMA. 2024;331:1233-1234.
PubMed
Breast Cancer and Pregnancy in Young BRCA Carriers-Reply.
JAMA. 2024;331:1234.
PubMed
3-year invasive disease-free survival with chemotherapy de-escalation using an
(18)F-FDG-PET-based, pathological complete response-adapted strategy in
HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2
trial.
Lancet. 2024 Apr 3:S0140-6736(24)00054-0. doi: 10.1016/S0140-6736(24)00054.
PubMed
Abstract available
Safe de-escalation of chemotherapy in HER2-positive early breast cancer.
Lancet. 2024 Apr 3:S0140-6736(24)00535-X. doi: 10.1016/S0140-6736(24)00535.
PubMed
MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II-III
HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study.
Lancet Oncol. 2024 Apr 5:S1470-2045(24)00104.
PubMed
Abstract available
TROP2 is highly expressed in triple-negative breast cancer CTCs and is a
potential marker for epithelial mesenchymal CTCs.
Mol Ther Oncol. 2024;32:200762.
PubMed
Abstract available
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases.
N Engl J Med. 2024;390:1163-1175.
PubMed
Abstract available
The PARTNER trial of neoadjuvant olaparib in triple-negative breast cancer.
Nature. 2024 Apr 8. doi: 10.1038/s41586-024-07384.
PubMed
Abstract available
Genomic spectrum of actionable alterations in serial cell free DNA (cfDNA)
analysis of patients with metastatic breast cancer.
NPJ Breast Cancer. 2024;10:27.
PubMed
Abstract available
NRF2 activation by cysteine as a survival mechanism for triple-negative breast
cancer cells.
Oncogene. 2024 Apr 10. doi: 10.1038/s41388-024-03025.
PubMed
Abstract available
An improved breast cancer classification with hybrid chaotic sand cat and Remora
Optimization feature selection algorithm.
PLoS One. 2024;19:e0300622.
PubMed
Abstract available
Higher number of steps is related to lower endogenous progesterone but not
estradiol levels in women.
PLoS One. 2024;19:e0299580.
PubMed
Abstract available
Performance of an AI System for Breast Cancer Detection on Screening Mammograms
from BreastScreen Norway.
Radiol Artif Intell. 2024 Apr 10:e230375. doi: 10.1148/ryai.230375.
PubMed
Abstract available
Long-term Mammography Screening Trends and Predictors of Return to Screening
after the COVID-19 Pandemic: Results from a Statewide Registry.
Radiol Imaging Cancer. 2024;6:e230161.
PubMed
Abstract available
Machine Learning Prediction of Lymph Node Metastasis in Breast Cancer:
Performance of a Multi-institutional MRI-based 4D Convolutional Neural Network.
Radiol Imaging Cancer. 2024;6:e230107.
PubMed
Abstract available
Use of an AI Score Combining Cancer Signs, Masking, and Risk to Select Patients
for Supplemental Breast Cancer Screening.
Radiology. 2024;311:e232535.
PubMed
Abstract available
AI-driven Selection of Candidates for Supplemental Breast Cancer Screening.
Radiology. 2024;311:e240447.
PubMed
Real-world experience with CDK4-6 inhibition in the old and oldest old with a
diagnosis of breast cancer.
Semin Oncol. 2024 Feb 22:S0093-7754(24)00003.
PubMed
Abstract available
Thank you for your interest in scientific medicine.